PARP1 bound to XRCC2 promotes tumor progression in colorectal cancer.
- Published in:
- Discover Oncology, 2024, v. 15, n. 1, p. 1, doi. 10.1007/s12672-024-01112-y
- By:
- Publication type:
- Article
Works by Yu, Zhige
Results: 3
1
2
Survival Benefit of Synchronous Lenvatinib Combined PD-1 Inhibitors for Advanced Hepatocellular Carcinoma Beyond Oligometastasis.
- Published in:
- ImmunoTargets & Therapy, 2024, v. 13, p. 305, doi. 10.2147/ITT.S458700
- By:
- Publication type:
- Article
3
The up-regulation of SYNCRIP promotes the proliferation and tumorigenesis via DNMT3A/p16 in colorectal cancer.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59575-6
- By:
- Publication type:
- Article